Literature DB >> 30546571

Successful balloon aortic valvuloplasty as a bridge therapy to transcatheter aortic valve implantation during the proctoring period.

Hiromu Yanagisawa1, Naritatsu Saito1, Masao Imai1, Kenji Minakata2, Takanari Fujita1, Shin Watanabe1, Hirotoshi Watanabe1, Kazuhiro Yamazaki2, Toshiaki Toyota1, Tomohiko Taniguchi1, Junichi Tazaki1, Satoshi Shizuta1, Hiroki Daijo3, Ryuzo Sakata2, Takeshi Kimura1.   

Abstract

In Japan, transcatheter aortic valve implantation (TAVI) with Edwards-SAPIEN XT valve (Edwards Lifesciences Inc., Irvine, CA, USA) started in October 2013. All institutions should undergo a training period to perform TAVI independently. Balloon aortic valvuloplasty (BAV) as a bridge to TAVI during the training period should be performed with caution to avoid severe aortic regurgitation (AR) because bailout TAVI is not possible. We present a case in which BAV was successfully performed as a bridge to TAVI during the training period. The patient was an 85-year-old man with medically uncontrollable congestive heart failure due to severe aortic valve stenosis. The aortic valve area was 0.60 cm2 with a left ventricular ejection fraction of 20%. TAVI was considered a safe but high-risk strategy owing to the unstable hemodynamic condition. We chose BAV as a bridge therapy to TAVI. The aortic annulus diameter was 25.3 mm on computed tomography scans. We chose a 20-mm balloon catheter to avoid BAV-induced AR. Transfemoral TAVI was performed successfully 16 days after BAV using a 26-mm SAPIEN XT valve. The postoperative course was uneventful. The case demonstrated BAV as a bridge therapy to TAVI can be safely and effectively performed during the training period. <Learning objective: All institutions should undergo a training period to start transcatheter aortic valve implantation (TAVI). Balloon aortic valvuloplasty (BAV) during the training period should be performed with caution. The present case suggests that BAV as a bridge therapy to TAVI can be safely performed during the training period. An accurate measurement of aortic annulus diameter and the use of an undersized balloon catheter might reduce the risk of BAV-related aortic regurgitation.>.

Entities:  

Keywords:  Balloon aortic valvuloplasty; Transcatheter aortic valve implantation; Transcatheter aortic valve replacement

Year:  2015        PMID: 30546571      PMCID: PMC6281847          DOI: 10.1016/j.jccase.2015.05.006

Source DB:  PubMed          Journal:  J Cardiol Cases        ISSN: 1878-5409


  10 in total

1.  Complications and outcome of balloon aortic valvuloplasty in high-risk or inoperable patients.

Authors:  Itsik Ben-Dor; Augusto D Pichard; Lowell F Satler; Steven A Goldstein; Asmir I Syed; Michael A Gaglia; Gaby Weissman; Gabriel Maluenda; Manuel A Gonzalez; Kohei Wakabayashi; Sara D Collins; Rebecca Torguson; Petros Okubagzi; Zhenyi Xue; Kenneth M Kent; Joseph Lindsay; Ron Waksman
Journal:  JACC Cardiovasc Interv       Date:  2010-11       Impact factor: 11.195

2.  Acute aortic regurgitation and hemodynamic collapse after balloon aortic valvuloplasty.

Authors:  Sasa Loncar; Gidon Perlman; David Planer; Yuval Meroz; Dan Gilon; Chaim Lotan; Haim D Danenberg
Journal:  Int J Cardiol       Date:  2013-12-04       Impact factor: 4.164

3.  The role of percutaneous balloon aortic valvuloplasty as a bridge for transcatheter aortic valve implantation.

Authors:  Francesco Saia; Cinzia Marrozzini; Carolina Moretti; Cristina Ciuca; Nevio Taglieri; Barbara Bordoni; Gianni Dall'ara; Laura Alessi; Valerio Lanzillotti; Maria Letizia Bacchi-Reggiani; Angelo Branzi; Antonio Marzocchi
Journal:  EuroIntervention       Date:  2011-10-30       Impact factor: 6.534

4.  Is balloon aortic valvuloplasty safe in patients with significant aortic valve regurgitation?

Authors:  Francesco Saia; Cinzia Marrozzini; Cristina Ciuca; Barbara Bordoni; Gianni Dall'Ara; Carolina Moretti; Nevio Taglieri; Tullio Palmerini; Angelo Branzi; Antonio Marzocchi
Journal:  Catheter Cardiovasc Interv       Date:  2011-11-30       Impact factor: 2.692

5.  Balloon aortic valvuloplasty in the era of transcatheter aortic valve replacement: acute and long-term outcomes.

Authors:  Hélène Eltchaninoff; Eric Durand; Bogdan Borz; Akira Furuta; Karim Bejar; Alexandre Canville; Ali Farhat; Chiara Fraccaro; Matthieu Godin; Christophe Tron; Rahul Sakhuja; Alain Cribier
Journal:  Am Heart J       Date:  2013-11-04       Impact factor: 4.749

6.  Balloon aortic valvuloplasty in adults: failure of procedure to improve long-term survival.

Authors:  E B Lieberman; T M Bashore; J B Hermiller; J S Wilson; K S Pieper; G P Keeler; C H Pierce; K B Kisslo; J K Harrison; C J Davidson
Journal:  J Am Coll Cardiol       Date:  1995-11-15       Impact factor: 24.094

7.  Staged balloon aortic valvuloplasty before standard aortic valve replacement in selected patients with severe aortic valve stenosis.

Authors:  Salah Eldien Altarabsheh; Kevin L Greason; Hartzell V Schaff; Rakesh M Suri; Zhuo Li; Verghese Mathew; Lyle D Joyce; Soon J Park; Joseph A Dearani
Journal:  Tex Heart Inst J       Date:  2014-04-01

8.  Percutaneous balloon aortic valvuloplasty. Acute and 30-day follow-up results in 674 patients from the NHLBI Balloon Valvuloplasty Registry.

Authors: 
Journal:  Circulation       Date:  1991-12       Impact factor: 29.690

9.  The Mansfield Scientific Aortic Valvuloplasty Registry: overview of acute hemodynamic results and procedural complications.

Authors:  R G McKay
Journal:  J Am Coll Cardiol       Date:  1991-02       Impact factor: 24.094

10.  Standalone balloon aortic valvuloplasty: indications and outcomes from the UK in the transcatheter valve era.

Authors:  Muhammed Z Khawaja; Manav Sohal; Haseeb Valli; Rafal Dworakowski; Stephen J Pettit; David Roy; James Newton; Heiko Schneider; Ganesh Manoharan; Sagar Doshi; Douglas Muir; David Roberts; James Nolan; Mark Gunning; Cameron Densem; Mark S Spence; Saqib Chowdhary; Vaikom S Mahadevan; Stephen J Brecker; Philip Maccarthy; Michael Mullen; Rodney H Stables; Bernard D Prendergast; Adam de Belder; Martyn Thomas; Simon Redwood; David Hildick-Smith
Journal:  Catheter Cardiovasc Interv       Date:  2013-02       Impact factor: 2.692

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.